Newamsterdam Pharma Company N.v. · NASDAQ:NAMS
Kastelein Johannes Jacob Pieter sold 50,246 Newamsterdam Pharma Company N.v. shares (Form 4)
Traded Sep 30, 2026 · Filed Oct 2, 2026
On Sep 30, 2026, Kastelein Johannes Jacob Pieter (Director, Chief Scientific Officer) sold 50,246 Newamsterdam Pharma Company N.v. shares at US$25.03 for US$1.26M under a trading plan, leaving 69,302 shares. Filed Oct 2, 2026 (Form 4).
- Sold
- 50,246 shares
- Price
- US$25.03
- Value
- US$1.26M
- Holding after
- 69,302 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Ordinary Shares | Option exercise | 50,246 | 119,548 | Indirect | |
| Sep 30, 2026 | Ordinary Shares | Sale | 50,246 | US$25.03 | 69,302 | Indirect |
Source
Related
- Newamsterdam Pharma Company N.v.
- Kastelein Johannes Jacob Pieter
- Newamsterdam Pharma Company N.v. shareholders
- Form 4 · Kastelein Johannes Jacob Pieter · Aug 25, 2026
- Form 4 · Davidson Michael H. · Sep 15, 2026
- Form 4 · Smither John W · Sep 9, 2026
- Form 4 · Gunning Robert William · Sep 3, 2026
- Form 4 · Kooij Louise Frederika · Jul 22, 2026
- Form 4 · Kooij Louise Frederika · Jun 24, 2026